Niagen CFO acquires shares via purchase plan
Niagen Bioscience Chief Financial Officer Pamir Ozan acquired additional company stock as part of compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Niagen Bioscience Chief Financial Officer Pamir Ozan acquired additional company stock as part of compensation. Ozan received 4,255 shares of common stock at $2.71 per share through the Employee Stock Purchase Plan, increasing direct holdings to about 11,627 shares. The filing also shows indirect ownership of about 2,220 shares held by the CFO's spouse.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,255 | $2.71 | $12K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d).
Key Figures
Key Terms
Employee Stock Purchase Plan financial
Rule 16b-3(c) regulatory
Rule 16b-3(d) regulatory
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Niagen Bioscience (NAGE) CFO Pamir Ozan report in this Form 4?
What is the nature of the indirect Niagen Bioscience (NAGE) holdings reported by the CFO?
What SEC rules are referenced in Niagen Bioscience (NAGE) CFO’s Form 4 footnote?
AI-generated analysis. How Rhea-AI works. Not financial advice.